The majority of Facebook's revenue is from advertising, not from the FB pay services mentioned in this article. The ad-based revenue from FB looks promising for Q1.
LNKD has a forward P/E of 90, FB has a forward P/E of 35. FB has more growth potential and is undervalued based on future earnings. LNKD took off after last quarter's earnings, FB could do the same with good earnings.
It's not a good strategy to short FB ahead of earnings, definitely not at the $26-$27 level. With the increase in short interest in this stock, and with the good chance of an earnings beat, the smart contrarian move is going long on Facebook for a possible short squeeze after earnings.
Arena Short Interest As Launch Of Belviq Approaches [View article]
You just made a good point, Healthythoughts, perhaps Belviq will be used off-label as a mild depression treatment while being prescribed for obesity. There's a big market for depressed overeaters.
It's Now Time For Vivus Investors To Watch Arena Numbers [View article]
Why shouldn't someone fifty pounds overweight be advised to use Belviq to help lose weight? Most obesity is also caused by lifestyle, so those obese people who will be prescribed Belviq are also using this as an edge, whereas they could just consume 1500 calories a day and exercise and all of them would lose weight. Science is showing being overweight, not just obese, leads to many serious health conditions.
"Apple's (AAPL) glory days are now behind it," said FBN's Shebly Seyrafi on Thursday morning with the stock at $450. On Sept. 13 - the day after the iPhone 5 launch and the shares at $680 - Seyrafi reiterated a Buy rating and boosted his price target to $1,000. (FBN now maintains an Outperform on Apple with a lowered target of $650.) [View news story]
I'd like to see some accountability from some of the investment firms against their analysts who deceived the public with their projections. Peter Misek of Jefferies and Sheyrafi should be unemployed now. I suspect they're collecting bonuses rather than pink slips though.
Herbalife: Icahn Cometh - Could The Stock Be Worth $103.93 Per Share? [View article]
Blackswans, Icahn refuted your point in the interview Friday when he said most of the sales growth is in the developing world. The call volume doesn't suggest this is going to fall and stay around $30 in the next few months.
Bret, I'm having trouble understanding your logic. How may "Facebook's Rally Be Over" if the fed is pushing everyone into stocks and shorting stocks is not advisable now?
4 February 'Feel Good' Factors For Apple Fanatics [View article]
Every word any SA author writes on AAPL is suspect following the 2012 AAPL crash. Almost all SA articles failed to warn investors of the previous AAPL spikes below predicted "bottoms." Traders may want to get in now, investors should wait until AAPL goes below $400 before even considering 1 share of this stock long-term.
Selling FB puts sounds good but without some rational reasons it's not worth publishing an article. For the reader's edification please explain your rationale as to why FB will drop in the coming week other than a hunch.
3 Reasons To Short Facebook [View article]
LNKD has a forward P/E of 90, FB has a forward P/E of 35. FB has more growth potential and is undervalued based on future earnings. LNKD took off after last quarter's earnings, FB could do the same with good earnings.
It's not a good strategy to short FB ahead of earnings, definitely not at the $26-$27 level. With the increase in short interest in this stock, and with the good chance of an earnings beat, the smart contrarian move is going long on Facebook for a possible short squeeze after earnings.
Bulls Make Money, Bears Make Money, Pigs Get Slaughtered [View article]
BlackBerry: Ignore The Noise And Take Advantage Of The Volatility [View article]
Arena Short Interest As Launch Of Belviq Approaches [View article]
3 Reasons To Short Facebook [View article]
It's Now Time For Vivus Investors To Watch Arena Numbers [View article]
"Apple's (AAPL) glory days are now behind it," said FBN's Shebly Seyrafi on Thursday morning with the stock at $450. On Sept. 13 - the day after the iPhone 5 launch and the shares at $680 - Seyrafi reiterated a Buy rating and boosted his price target to $1,000. (FBN now maintains an Outperform on Apple with a lowered target of $650.) [View news story]
Watch Out AT&T: Facebook Could Take Over The Smartphone [View article]
Check out the insider transactions for Facebook. I've never seen a stock with so many large insider sales starting at the inflated IPO price of $38.
"Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours."
No downside to FB stock mentioned in this article, it's odd you aren't a stockholder in FB.
Watch Out AT&T: Facebook Could Take Over The Smartphone [View article]
Deceptively worded. FB stock has been falling since January.
Dan Loeb's Position In Herbalife [View article]
Herbalife: Icahn Cometh - Could The Stock Be Worth $103.93 Per Share? [View article]
Facebook's Rally May Be Over [View article]
4 February 'Feel Good' Factors For Apple Fanatics [View article]
Why Investors Should Consider Selling The Rally In RIM Shares Now [View article]
The more logical interpretation of the chart is that RIMM has broken key resistance levels, we'll see if these highs hold next week.
Schadenfreude Suits Me Just Fine [View article]